While Biogen’s tau-targeting therapy didn’t demonstrate improvement on a dementia severity scale, the company touted ...
In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results